Gastric cancer
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: ECOG PS 0-2 Patients who are going to receive platinum combination chemotherapy Patients who have written informed consent Patients over 70 years old
Exclusion criteria
Exclusion criteria: Recurrent cases during preoperative or postoperative chemotherapy Cases of clinical trial Patients who can not understand disease condition due to severe cognitive impairment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Adverse event rates of grade 3-4 during first-line chemotherapy | — |
Secondary
| Measure | Time frame |
|---|---|
| RDI(Relative dose intensity) during first-line chemotherapy, overall survival (OS), progression free survival (PFS), overall response rate (ORR), time to treatment failure (TTF), and the relationship between GA scores and adverse events or treatment results | — |
Countries
Japan
Contacts
Okayama University Hospital Gastroenterology